These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 26337468

  • 1. Dynamic cellular and molecular modulations of diabetes mediated head and neck carcinogenesis.
    Liu CJ, Chang WJ, Chen CY, Sun FJ, Cheng HW, Chen TY, Lin SC, Li WC.
    Oncotarget; 2015 Oct 06; 6(30):29268-84. PubMed ID: 26337468
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Carboxyl-Terminal Modulator Protein Positively Acts as an Oncogenic Driver in Head and Neck Squamous Cell Carcinoma via Regulating Akt phosphorylation.
    Chang JW, Jung SN, Kim JH, Shim GA, Park HS, Liu L, Kim JM, Park J, Koo BS.
    Sci Rep; 2016 Jun 22; 6():28503. PubMed ID: 27328758
    [Abstract] [Full Text] [Related]

  • 5. MEK Inhibitor PD-0325901 Overcomes Resistance to PI3K/mTOR Inhibitor PF-5212384 and Potentiates Antitumor Effects in Human Head and Neck Squamous Cell Carcinoma.
    Mohan S, Vander Broek R, Shah S, Eytan DF, Pierce ML, Carlson SG, Coupar JF, Zhang J, Cheng H, Chen Z, Van Waes C.
    Clin Cancer Res; 2015 Sep 01; 21(17):3946-56. PubMed ID: 25977343
    [Abstract] [Full Text] [Related]

  • 6. Stable SET knockdown in head and neck squamous cell carcinoma promotes cell invasion and the mesenchymal-like phenotype in vitro, as well as necrosis, cisplatin sensitivity and lymph node metastasis in xenograft tumor models.
    Sobral LM, Sousa LO, Coletta RD, Cabral H, Greene LJ, Tajara EH, Gutkind JS, Curti C, Leopoldino AM.
    Mol Cancer; 2014 Feb 20; 13():32. PubMed ID: 24555657
    [Abstract] [Full Text] [Related]

  • 7. Comparative secretome analysis of epithelial and mesenchymal subpopulations of head and neck squamous cell carcinoma identifies S100A4 as a potential therapeutic target.
    Rasanen K, Sriswasdi S, Valiga A, Tang HY, Zhang G, Perego M, Somasundaram R, Li L, Speicher K, Klein-Szanto AJ, Basu D, Rustgi AK, Speicher DW, Herlyn M.
    Mol Cell Proteomics; 2013 Dec 20; 12(12):3778-92. PubMed ID: 24037664
    [Abstract] [Full Text] [Related]

  • 8. Elevated RET expression enhances EGFR activation and mediates EGFR inhibitor resistance in head and neck squamous cell carcinoma.
    Lin C, Lu W, Ren Z, Tang Y, Zhang C, Yang R, Chen Y, Cao W, Wang L, Wang X, Ji T.
    Cancer Lett; 2016 Jul 10; 377(1):1-10. PubMed ID: 27090738
    [Abstract] [Full Text] [Related]

  • 9. Nicotine promotes lymph node metastasis and cetuximab resistance in head and neck squamous cell carcinoma.
    Shimizu R, Ibaragi S, Eguchi T, Kuwajima D, Kodama S, Nishioka T, Okui T, Obata K, Takabatake K, Kawai H, Ono K, Okamoto K, Nagatsuka H, Sasaki A.
    Int J Oncol; 2019 Jan 10; 54(1):283-294. PubMed ID: 30431077
    [Abstract] [Full Text] [Related]

  • 10. Anterior gradient protein 2 expression in high grade head and neck squamous cell carcinoma correlated with cancer stem cell and epithelial mesenchymal transition.
    Ma SR, Wang WM, Huang CF, Zhang WF, Sun ZJ.
    Oncotarget; 2015 Apr 20; 6(11):8807-21. PubMed ID: 25871396
    [Abstract] [Full Text] [Related]

  • 11. Lupeol suppresses cisplatin-induced nuclear factor-kappaB activation in head and neck squamous cell carcinoma and inhibits local invasion and nodal metastasis in an orthotopic nude mouse model.
    Lee TK, Poon RT, Wo JY, Ma S, Guan XY, Myers JN, Altevogt P, Yuen AP.
    Cancer Res; 2007 Sep 15; 67(18):8800-9. PubMed ID: 17875721
    [Abstract] [Full Text] [Related]

  • 12. CSC-3436 inhibits TWIST-induced epithelial-mesenchymal transition via the suppression of Twist/Bmi1/Akt pathway in head and neck squamous cell carcinoma.
    Lai YJ, Yu WN, Kuo SC, Ho CT, Hung CM, Way TD, Chen CT.
    J Cell Physiol; 2019 Jun 15; 234(6):9118-9129. PubMed ID: 30341909
    [Abstract] [Full Text] [Related]

  • 13. p70S6K promotes IL-6-induced epithelial-mesenchymal transition and metastasis of head and neck squamous cell carcinoma.
    Wu D, Cheng J, Sun G, Wu S, Li M, Gao Z, Zhai S, Li P, Su D, Wang X.
    Oncotarget; 2016 Jun 14; 7(24):36539-36550. PubMed ID: 27174914
    [Abstract] [Full Text] [Related]

  • 14. Targeting TORC1/2 enhances sensitivity to EGFR inhibitors in head and neck cancer preclinical models.
    Cassell A, Freilino ML, Lee J, Barr S, Wang L, Panahandeh MC, Thomas SM, Grandis JR.
    Neoplasia; 2012 Nov 14; 14(11):1005-14. PubMed ID: 23226094
    [Abstract] [Full Text] [Related]

  • 15. Improved clearance during treatment of HPV-positive head and neck cancer through mTOR inhibition.
    Coppock JD, Wieking BG, Molinolo AA, Gutkind JS, Miskimins WK, Lee JH.
    Neoplasia; 2013 Jun 14; 15(6):620-30. PubMed ID: 23730210
    [Abstract] [Full Text] [Related]

  • 16. Salinomycin induces cell death and differentiation in head and neck squamous cell carcinoma stem cells despite activation of epithelial-mesenchymal transition and Akt.
    Kuo SZ, Blair KJ, Rahimy E, Kiang A, Abhold E, Fan JB, Wang-Rodriguez J, Altuna X, Ongkeko WM.
    BMC Cancer; 2012 Nov 24; 12():556. PubMed ID: 23176396
    [Abstract] [Full Text] [Related]

  • 17. Impact of PI3K/AKT/mTOR pathway activation on the prognosis of patients with head and neck squamous cell carcinomas.
    García-Carracedo D, Villaronga MÁ, Álvarez-Teijeiro S, Hermida-Prado F, Santamaría I, Allonca E, Suárez-Fernández L, Gonzalez MV, Balbín M, Astudillo A, Martínez-Camblor P, Su GH, Rodrigo JP, García-Pedrero JM.
    Oncotarget; 2016 May 17; 7(20):29780-93. PubMed ID: 27119232
    [Abstract] [Full Text] [Related]

  • 18. Deregulation of the miR-222-ABCG2 regulatory module in tongue squamous cell carcinoma contributes to chemoresistance and enhanced migratory/invasive potential.
    Zhao L, Ren Y, Tang H, Wang W, He Q, Sun J, Zhou X, Wang A.
    Oncotarget; 2015 Dec 29; 6(42):44538-50. PubMed ID: 26517090
    [Abstract] [Full Text] [Related]

  • 19. The upregulated α-catulin expression was involved in head-neck squamous cell carcinogenesis by promoting proliferation, migration, invasion, and epithelial to mesenchymal transition.
    Zhang Z, Yang XF, Huang KQ, Ren L, Zhao S, Gou WF, Shen DF, Sun HZ, Takano Y, Zheng HC.
    Tumour Biol; 2016 Feb 29; 37(2):1671-81. PubMed ID: 26311049
    [Abstract] [Full Text] [Related]

  • 20. Mutations of the LIM protein AJUBA mediate sensitivity of head and neck squamous cell carcinoma to treatment with cell-cycle inhibitors.
    Zhang M, Singh R, Peng S, Mazumdar T, Sambandam V, Shen L, Tong P, Li L, Kalu NN, Pickering CR, Frederick M, Myers JN, Wang J, Johnson FM.
    Cancer Lett; 2017 Apr 28; 392():71-82. PubMed ID: 28126323
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.